SEC Form 4 · accession 0001415889-15-000057
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Jemil Esber
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2015 | A | 37,500 | $0.00 | A | 1,826,284 | D |
Table II — derivative securities
No Table II lines on this filing.